Radiomics from edema zone predicts progression-free survival in postoperative glioma patients
This retrospective cohort study included 89 postoperative glioma patients and evaluated a radiomics model derived from the 2-cm edema zone surrounding the postoperative residual cavity using habitat analysis based on multimodal MRI, integrated with clinical data. The model was compared to clinical and traditional radiomic models, with progression-free survival (PFS) as the primary outcome. Main results showed the model predicted 1-year PFS with a time-dependent AUC of 0.813, 2-year PFS with an AUC of 0.933, and 3-year PFS with an AUC of 0.930, while a high-risk habitat nomogram had a C-index of 0.916. Safety and tolerability data were not reported. Key limitations include the retrospective design, small sample size of 89 patients, and lack of reported follow-up duration, which may affect generalizability. The study suggests this approach could aid in targeting postoperative radiotherapy, but clinicians should interpret findings cautiously due to the observational nature and need for prospective validation.